Navigation Links
Response Biomedical Corporation Moves to New Facility
Date:3/20/2008

VANCOUVER, March 20 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) today announced that it plans to move to its new state-of-the-art global headquarters located at 1781 - 75th Avenue West, Vancouver, British Columbia on March 31, 2008.

The 46,000 square foot single-occupant specialized use facility was specifically designed and constructed for development and GMP manufacturing and distribution of point-of-care (POC) medical diagnostic test kits. Response Biomedical designs, develops, manufactures and distributes rapid POC tests for use with its portable RAMP(R) platform for clinical and environmental applications. The new facility should allow manufacturing scale-up from approximately 500,000 tests currently manufactured per year to four million tests per year by mid-2008, based on partner demand. In this new facility, the Company believes it can eventually escalate test-manufacturing capacity to over 15 million tests per year.

"We are very pleased to be moving to our new home," said S. Wayne Kay, Chief Executive Officer. "This new facility is expected to meet the demands of our current partners, 3M Company and Shionogi & Co. of Japan, as well as the projected demands of our planned cardiovascular partner."

The new facility features multiple specialized laboratories with environmental controls and monitoring systems required for product development, manufacturing and distribution in compliance with requirements established by global organizations such as the International Organization for Standardization (ISO) and individual regulatory authorities such as the U.S. Food and Drug Administration (FDA), Health Canada and the Ministry of Health, Labor and Welfare in Japan.

The Company announced in May 2007 that it had entered into a long-term agreement with Alexandria Real Estate Equities, Inc. to lease the single-tenant facility. Initial capital modifications to the facility were financed by Alexandri
'/>"/>

SOURCE Response Biomedical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Response Biomedical Corp. - Year End 2007 Earnings Webcast and Conference Call - March 31, 2008
2. Statement from Eli Lilly and Company: Response to Todays New York Times Article, Lilly E-Mail Discussed Off-Label Drug Use
3. An efficient response in primary care would reduce the use of hospitals by elderly people
4. Allergic response tied to lipid molecules in cell membrane
5. Empire Blue Cross Blue Shield Statement in Response to New York Attorney Generals Recent Subpoenas
6. Genetic Test Predicts Response to Warfarin
7. Lupus Advocates Seek Increased Federal Response to Life-Changing, Life-Threatening Disease Affecting 1.5 Million Americans
8. Gene expression differences between Europeans and Africans affect response to drugs, infections
9. Statement by Dr. Edward Jones, Chairman of Kidney Care Partners in Response to CMS Payment Bundling Report
10. Protein shines light on cancer response
11. Missing Chromosome Improves Response to Brain Tumor Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... State University Spokane have developed a new way ... off behind the wheel. , Their recently patented ... more variable in drowsy driversand offers an affordable ... driver drowsiness detection systems. , Van Dongen"Video-based systems ... is drifting out of its lane are cumbersome ...
(Date:4/23/2014)... University researcher is looking to give exercise enthusiasts the ... latest research shows that a cyber buddy can help. ... for Health Journal , is the first to indicate ... motivator during exercise, a software-generated partner also can be ... isn,t real can still motivate people to give greater ...
(Date:4/23/2014)... rats exposed to high-energy particles, simulating conditions astronauts would ... in attention and slower reaction times, even when the ... The cognitive impairments which affected a large subset, ... to be linked to protein changes in the brain, ... true in humans, suggest it may be possible to ...
(Date:4/23/2014)... researchers have identified an important enzyme pathway that helps ... few chromosomes, a condition that has been directly linked ... professor of biochemistry, found that near the end of ... that ensures any breaks in DNA are fully repaired ... to daughter cells. This process helps safeguard against some ...
(Date:4/23/2014)... has long been considered to be between 180 and ... used refined microscopic techniques that indicate a much smaller ... tract is only as large as a normal studio ... which passes from the mouth through the esophagus and ... 5 meters in a normal adult, and is built ...
Breaking Medicine News(10 mins):Health News:WSU innovation improves drowsy driver detection 2Health News:Cyber buddy is better than 'no buddy' 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 3Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2Health News:The surface area of the digestive tract 'only' as large as a studio apartment 2
... THE MARKET FORECAST FOR THE DRUG, WALTHAM, Mass., ... Resources, is available to discuss the impact of the ... the,first integrase inhibitor drug which blocks the ability of ... Integrase inhibitors are a novel class of HIV drugs ...
... New products, a growing world,population expected to ... as the,aging of that population, will push anesthesia ... according to Anesthesia Drugs: Worldwide Markets, a,new report ... surgical procedures required anesthetic,administration worldwide in 2006, and ...
... SYK ) disclosed today that the United ... inquiry of the Company regarding possible,violations of the ... sale,of medical devices in certain foreign countries. Stryker ... Commission regarding this,informal investigation. Stryker Corporation is ...
... 118 patients with portal vein thrombosis, noncirrhotic and nontumoral ... well tolerated bleed. Cirrhosis and tumor related portal vein ... state as a cause of portal vein thrombosis is ... number of patients. , A research article to be ...
... health information program recognized for helping to reduce, ... self-care., INDIANAPOLIS, Oct. 12 WellPoint NextRx, ... has received a 2007,Disease Management Leadership Award from ... innovative, Web-based Health Envelope(R) Program.,WellPoint NextRx is owned ...
... /Xinhua-PRNewswire-FirstCall/ -- China,Medicine Corporation ("CMC") (OTC ... prescription and over the counter pharmaceutical ... of Chinese herbs),Chinese herbs, nutritional supplements, ... today announced the Company,s ADTZ,(Aflatoxin-detoxifizyme) project ...
Cached Medicine News:Health News:Impending FDA Approval Decision on the First HIV Integrase Inhibitor Can Have Significant Impact for Patients 2Health News:Anesthesia Drugs Market to Grow to $4.3 Billion by 2011 as Populations and Uses for Anesthesia Increase 2Health News:Portal vein thrombosis is common in extraportal vein obstruction 2Health News:WellPoint NextRx Receives National Leadership Award for Innovative Web Tool 2Health News:WellPoint NextRx Receives National Leadership Award for Innovative Web Tool 3Health News:China Medicine's ADTZ Project Has Been Selected as One of Six Patent Commercialization Projects in Guangdong Province 2
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Global ... Systems -- Focus on End Users ... OBJECTIVES A drug delivery system ...
(Date:1/14/2014)... , Jan. 14, 2014 HeartWare International, Inc ... of less invasive, miniaturized circulatory support technologies that are ... that it expects revenues for the fourth quarter of ... 2013 revenues to approximately $208 million. "Our ...
(Date:1/14/2014)... HARRISBURG, Pa. , Jan. 14, 2014 Dynamic Healthcare ... ("GMH"), announced today that it acquired Progressive Home Medical Equipment, ... January 7, 2014. The terms of the acquisition were not ... medical equipment ("DME") company providing a wide range of sleep, ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... April 13, 2011 Cephalon, Inc. (Nasdaq: ... CXS Holdings Pty Ltd (Cephalon), has lodged the offer ... for ChemGenex Pharmaceuticals Limited (ASX: CXS) (ChemGenex) with the ... offering a 58 percent premium to the one-month volume ...
... Pharmaceuticals, Inc., the leader in the development of neurosteroids ... of a $3 million grant by the U.S. Department ... the treatment of Fragile-X Syndrome (FXS). Ganaxolone modulates GABA-A ... Early research suggests that normalizing neurosteroid levels with ganaxolone ...
Cached Medicine Technology:Cephalon Lodges Bidder's Statement for A$167 Million Offer for ChemGenex Pharmaceuticals 2Cephalon Lodges Bidder's Statement for A$167 Million Offer for ChemGenex Pharmaceuticals 3Marinus Pharmaceuticals Announces U.S. Department of Defense Grant to Study Ganaxolone in Fragile-X Syndrome 2
Tube for Right Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Gradua...
Laser resistant tubes for use with CO2 and KTP Lasers., ,Designed for airway management during laser surgery of the larynx or other areas in close proximity to the trachea....
Laryngectomy Tubes with special J-shape for convenient placement through a tracheostomy stoma....
SPIRAL-FLEX® Reinforced Oral/Nasal Cuffed Endotracheal Tubes...
Medicine Products: